Edwards Lifesciences Corporation
EWFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
5,440
Cost of Revenue
1,118
Gross Profit
4,322
Gross Margin
79.5%
Operating Income
1,379
Operating Margin
25.3%
Net Income
4,175
Net Margin
76.7%
EPS (Basic)
$6.98
EPS (Diluted)
$6.97
EBITDA
1,723
EBITDA Margin
31.7%
2023
12/31/2023
Revenue
5,010
Cost of Revenue
1,037
Gross Profit
3,973
Gross Margin
79.3%
Operating Income
1,427
Operating Margin
28.5%
Net Income
1,402
Net Margin
28.0%
EPS (Basic)
$2.31
EPS (Diluted)
$2.30
EBITDA
1,535
EBITDA Margin
30.6%
2022
12/31/2022
Revenue
5,382
Cost of Revenue
1,167
Gross Profit
4,215
Gross Margin
78.3%
Operating Income
1,702
Operating Margin
31.6%
Net Income
1,522
Net Margin
28.3%
EPS (Basic)
$2.46
EPS (Diluted)
$2.44
EBITDA
1,960
EBITDA Margin
36.4%
2021
12/31/2021
Revenue
5,233
Cost of Revenue
1,226
Gross Profit
4,007
Gross Margin
76.6%
Operating Income
1,610
Operating Margin
30.8%
Net Income
1,503
Net Margin
28.7%
EPS (Basic)
$2.41
EPS (Diluted)
$2.38
EBITDA
1,890
EBITDA Margin
36.1%
2020
12/31/2020
Revenue
4,386
Cost of Revenue
1,099
Gross Profit
3,287
Gross Margin
74.9%
Operating Income
1,296
Operating Margin
29.5%
Net Income
823
Net Margin
18.8%
EPS (Basic)
$1.32
EPS (Diluted)
$1.30
EBITDA
1,074
EBITDA Margin
24.5%